Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|September 19, 2024
Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinomaKelvin Yan, Darren Wt Lim, Brigette B B Y Ma
Hematology/Oncology Clinics of North America|January 7, 2003
Clinical trial designs for targeted agentsBrigette B Y Ma, Carolyn D Britten, Lillian L Siu
Current Opinion in Oncology|March 17, 2020
The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinomaEdwin Pun Hui, Brigette B Y Ma, Anthony T C Chan
Nature Medicine|September 14, 2021
The expanding universe of checkpoint inhibitors for nasopharyngeal cancerBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Lancet (London, England)|October 22, 2025
The arrival of antibody drug conjugates in nasopharyngeal cancerAnthony T C Chan, Edwin P Hui, Brigette B Y Ma
Cancer Science|May 24, 2008
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directionsBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Expert Opinion on Investigational Drugs|April 28, 2017
Investigational drugs for nasopharyngeal carcinomaBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agentsBrigette B Y Ma, Robert G Bristow, John Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methodsPeter M L Teo, Brigette B Y Ma, Anthony T C Chan
Cancers|September 28, 2024
Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic TherapyJason C S Ho, Brigette B Y Ma, James C H Chow
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|September 19, 2024
Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinomaKelvin Yan, Darren Wt Lim, Brigette B B Y Ma
Hematology/Oncology Clinics of North America|January 7, 2003
Clinical trial designs for targeted agentsBrigette B Y Ma, Carolyn D Britten, Lillian L Siu
Current Opinion in Oncology|March 17, 2020
The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinomaEdwin Pun Hui, Brigette B Y Ma, Anthony T C Chan
Nature Medicine|September 14, 2021
The expanding universe of checkpoint inhibitors for nasopharyngeal cancerBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Lancet (London, England)|October 22, 2025
The arrival of antibody drug conjugates in nasopharyngeal cancerAnthony T C Chan, Edwin P Hui, Brigette B Y Ma
Cancer Science|May 24, 2008
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directionsBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Expert Opinion on Investigational Drugs|April 28, 2017
Investigational drugs for nasopharyngeal carcinomaBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agentsBrigette B Y Ma, Robert G Bristow, John Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methodsPeter M L Teo, Brigette B Y Ma, Anthony T C Chan
Cancers|September 28, 2024
Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic TherapyJason C S Ho, Brigette B Y Ma, James C H Chow
Pageof 15